BRIEF published on 07/09/2024 at 07:05, 2 years 2 months ago CARMAT dynamise ses ventes et affirme son développement Développement Commercial CARMAT Aeson® Implantations Étude EFICAS
PRESS RELEASE published on 07/09/2024 at 07:00, 2 years 2 months ago Inside Information / Other news releases CARMAT exceeds 2023 sales, with €3.2M revenue in H1 2024 & 20 Aeson® heart implants. Confidence in growth outlook maintained. EFICAS study progressing well Financial Results Sales Momentum CARMAT EFICAS Study Aeson Heart Implants
PRESS RELEASE published on 07/09/2024 at 07:00, 2 years 2 months ago Informations privilégiées / Autres communiqués CARMAT accélère ses ventes avec 20 implantations du cœur artificiel Aeson® réalisées au premier semestre 2024, dépassant le CA annuel 2023. Confiance renouvelée dans ses perspectives de développement Développement Commercial CARMAT Aeson® Étude EFICAS Dynamique Des Ventes
BRIEF published on 07/08/2024 at 07:05, 2 years 2 months ago CARMAT fera son point semestriel le 9 juillet 2024 Mise À Jour Financière Coeur Artificiel TAPIS DE VOITURE Conférence Vidéo
BRIEF published on 07/08/2024 at 07:05, 2 years 2 months ago CARMAT to Provide Half-Year Update on July 9, 2024 Financial Update CARMAT Artificial Heart Videoconference
PRESS RELEASE published on 07/08/2024 at 07:00, 2 years 2 months ago Inside Information / Other news releases CARMAT to provide a half-year update and host a videoconference in French on July 9, 2024. The update will cover advancements of the Aeson artificial heart and key company developments CARMAT Aeson Artificial Heart Videoconference Half-year Update Therapeutic Alternative
BRIEF published on 06/25/2024 at 07:05, 2 years 2 months ago Nouvelle gouvernance chez CARMAT Gouvernance Nomination CARMAT Insuffisance Cardiaque Pierre Bastid
BRIEF published on 06/25/2024 at 07:05, 2 years 2 months ago New governance at CARMAT Governance Nomination Heart Failure CARMAT Pierre Bastid
PRESS RELEASE published on 06/25/2024 at 07:00, 2 years 2 months ago Informations privilégiées / Autres communiqués CARMAT annonce une évolution de sa gouvernance avec la nomination de Pierre Bastid comme président du conseil d'administration et la démission d'André Muller. Le conseil compte désormais 10 membres dont 5 indépendants Gouvernance Évolutions Conseil D'administration CARMAT Pierre Bastid
PRESS RELEASE published on 06/25/2024 at 07:00, 2 years 2 months ago Inside Information / Other news releases CARMAT appoints Pierre Bastid as Chairman of the Board and announces retirement of André Muller. The company aims to accelerate commercial development with these governance updates CARMAT Commercial Development Pierre Bastid Governance Updates Aeson Artificial Heart
Published on 09/12/2026 at 02:35, 11 hours 32 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 15 hours 7 minutes ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 22:05, 16 hours 2 minutes ago Usha Resources Announces Leadership Transition
Published on 09/11/2026 at 21:25, 16 hours 42 minutes ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 21 hours 7 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 07:30, 6 hours 36 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 15 hours 51 minutes ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 15 hours 56 minutes ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 18 hours 22 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 19 hours 51 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 7 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 1 day 18 hours ago Availability of the 2026 Interim Financial Report
